On June 8, four Nifty500 stocks were highlighted in the RSI Trending Up scan based on StockEdge.com data, indicating strengthening momentum as RSI crossed above 50 from lower levels. The signal suggests improving price strength and potential bullish continuation, which traders often track for identifying possible short-term buying opportunities.
Vodafone Idea and Bharti Airtel shares will be in focus after the Bombay High Court quashed one-time spectrum charge demands, granting relief of about Rs 20,000 crore. The court ruled the government lacked legal authority, though the matter remains pending before the Supreme Court.
Global capital flows are shifting away from semiconductor-heavy markets like South Korea and Taiwan. This tech-led meltdown presents an opportunity for India. Foreign investors may return to Indian markets, which are seen as a diversified domestic-economy-led alternative. This shift could lead to an explosive rally for Indian stocks.
Investors have a final chance today to purchase shares in Tata Chemicals, Tata Elxsi, and Tata Investment Corporation. These three Tata Group companies have set June 10 as the record date for their upcoming dividends. Shareholders buying today will be eligible for a combined dividend payout of Rs 89.4. This presents an opportunity for investors to secure these corporate rewards.
Gold prices dipped for a third consecutive session, influenced by rising Treasury yields and ongoing Middle East conflict concerns. Goldman Sachs anticipates the Fed will hold rates steady through 2026, while Citi lowered its near-term gold price target due to expected higher U.S. interest rates.
Indian stock markets tumbled nearly 1% on Monday, mirroring a broader Asian decline. Renewed Middle East hostilities fueled oil prices, while global investors shifted away from AI stocks. The Nifty closed down 243.7 points at 23,123, and the Sensex fell 719.08 points to 73,524.26, reflecting heightened market anxiety.
The government has launched a two-day offer for sale in NLC India, aiming to divest up to 3% stake through a base offer and greenshoe option. The issue, priced at a discount to the market rate, could raise up to Rs 1,263 crore and forms part of the broader disinvestment programme.
Lilly presented full data from two retatrutide trials, one in treatment naive type 2 diabetes patients and another in patients ‌with obesity, â at the â American Diabetes Association meeting in New Orleans.
Two promoter-group charitable entities of Motilal Oswal Financial Services sold shares worth about Rs 153 crore through block deals, with HDFC Life acquiring the entire stake. The transaction reflects strong institutional interest in financial-sector stocks and does not indicate any change in promoter control.
Warning! Information Posting in this website is only for educational purpose. We are not responsible for losses incurred in Trading based on this information.